Qian Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qian Zhou has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Chenfeng Ji
Department of Psychological Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China
2 shared publications - Yanli Luo
Department of Psychological Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China
2 shared publications Chen Zhang
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication- Daihui Peng
Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 200030 Shanghai, China
1 shared publication Fay Y. Womer
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri
1 shared publication- Fei Wang
Early Intervention Unit, Department of Psychiatry The Affiliated Brain Hospital of Nanjing Medical University Nanjing China
1 shared publication
Latest Publications
- Open Access
Group interpersonal psychotherapy for generalized anxiety disorder: development process and a pilot test
- 15 January 2019
- Published by Wiley in Human Brain Mapping
- Vol. 40 (7) , 2200-2211
Dynamic changes of functional segregation and integration in vulnerability and resilience to schizophrenia
Schizophrenia (SZ) is a highly heritable disease with neurodevelopmental origins and significant functional brain network dysfunction. Functional network is heavily influenced by neurodevelopment processes and can be characterized by the degree of segregation and integration. This study examines functional segregation and integration in SZ and their first‐degree relatives (high risk [HR]) to better understand the dynamic changes in vulnerability and resiliency, and disease markers. Resting‐state functional magnetic resonance imaging data acquired from 137 SZ, 89 HR, and 210 healthy controls (HCs). Small‐worldness σ was computed at voxel level to quantify balance between segregation and integration. Interregional functional associations were examined based on Euclidean distance between regions and reflect degree of segregation and integration. Distance strength maps were used to localize regions of altered distance‐based functional connectivity. σ was significantly decreased in SZ compared to HC, with no differences in high risk (HR). In three‐group comparison, significant differences were noted in short‐range connectivity (primarily in the primary sensory, motor and their association cortices, and the thalamus) and medium/long‐range connectivity (in the prefrontal cortices [PFCs]). Decreased short‐ and increased medium/long‐range connectivity was found in SZ. Decreased short‐range connectivity was seen in SZ and HR, while HR had decreased medium/long‐range connectivity. We observed disrupted balance between segregation and integration in SZ, whereas relatively preserved in HR. Similarities and differences between SZ and HR, specific changes of SZ were found. These might reflect dynamic changes of segregation in primary cortices and integration in PFCs in vulnerability and resilience, and disease markers in SZ.
- 15 January 2019
- Published by Wiley in Human Brain Mapping
- Vol. 40 (7) , 2200-2211
Dynamic changes of functional segregation and integration in vulnerability and resilience to schizophrenia
Schizophrenia (SZ) is a highly heritable disease with neurodevelopmental origins and significant functional brain network dysfunction. Functional network is heavily influenced by neurodevelopment processes and can be characterized by the degree of segregation and integration. This study examines functional segregation and integration in SZ and their first‐degree relatives (high risk [HR]) to better understand the dynamic changes in vulnerability and resiliency, and disease markers. Resting‐state functional magnetic resonance imaging data acquired from 137 SZ, 89 HR, and 210 healthy controls (HCs). Small‐worldness σ was computed at voxel level to quantify balance between segregation and integration. Interregional functional associations were examined based on Euclidean distance between regions and reflect degree of segregation and integration. Distance strength maps were used to localize regions of altered distance‐based functional connectivity. σ was significantly decreased in SZ compared to HC, with no differences in high risk (HR). In three‐group comparison, significant differences were noted in short‐range connectivity (primarily in the primary sensory, motor and their association cortices, and the thalamus) and medium/long‐range connectivity (in the prefrontal cortices [PFCs]). Decreased short‐ and increased medium/long‐range connectivity was found in SZ. Decreased short‐range connectivity was seen in SZ and HR, while HR had decreased medium/long‐range connectivity. We observed disrupted balance between segregation and integration in SZ, whereas relatively preserved in HR. Similarities and differences between SZ and HR, specific changes of SZ were found. These might reflect dynamic changes of segregation in primary cortices and integration in PFCs in vulnerability and resilience, and disease markers in SZ.
- 11 July 2018
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 25 (2) , 215-222
Clinical characteristics associated with therapeutic nonadherence of the patients with major depressive disorder: A report on the National Survey on Symptomatology of Depression in China
Summary: Aims: Nonadherence is one of the leading challenges to treatment of the major depressive disorder (MDD). Few studies have systematically analyzed the relationship between clinical characteristics, especially symptoms of depressive patients and their therapeutic nonadherence over a relatively large sample. This study aimed to investigate factors of nonadherence in a nationwide survey in China.Methods: Participants with MDD who met the criteria of Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM‐IV) were recruited from 32 sites throughout China. Patients were all over 16 years old. A doctor‐rating questionnaire with 64 symptoms based on DSM‐IV was constructed to evaluate depression‐related feeling and behavior. Single‐factor logistic regression was utilized to screen variables, and multifactor logistic regressive analysis was used to identify which factors were risk or protective for nonadherence. We included 882 patients of poor adherence and 857 patients of good adherence.Results: Recurrence, untreated first episode, tricyclic antidepressant (TCA)‐treated first episode, antidepressant‐only‐treated current episode, decrease or loss of interest, more somatic symptoms, and “atypical” symptoms were risk factors for nonadherence, whereas selective noradrenaline reuptake inhibitor (SNRI)‐treated first episode was a protecting factor.Conclusion: Clinical characteristics may play an important role in predicting nonadherence. Doctors may have to pay much attention on patients with these factors and should keep on discussing them with patients.
- 11 July 2018
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 25 (2) , 215-222
Clinical characteristics associated with therapeutic nonadherence of the patients with major depressive disorder: A report on the National Survey on Symptomatology of Depression in China
Summary: Aims: Nonadherence is one of the leading challenges to treatment of the major depressive disorder (MDD). Few studies have systematically analyzed the relationship between clinical characteristics, especially symptoms of depressive patients and their therapeutic nonadherence over a relatively large sample. This study aimed to investigate factors of nonadherence in a nationwide survey in China.Methods: Participants with MDD who met the criteria of Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM‐IV) were recruited from 32 sites throughout China. Patients were all over 16 years old. A doctor‐rating questionnaire with 64 symptoms based on DSM‐IV was constructed to evaluate depression‐related feeling and behavior. Single‐factor logistic regression was utilized to screen variables, and multifactor logistic regressive analysis was used to identify which factors were risk or protective for nonadherence. We included 882 patients of poor adherence and 857 patients of good adherence.Results: Recurrence, untreated first episode, tricyclic antidepressant (TCA)‐treated first episode, antidepressant‐only‐treated current episode, decrease or loss of interest, more somatic symptoms, and “atypical” symptoms were risk factors for nonadherence, whereas selective noradrenaline reuptake inhibitor (SNRI)‐treated first episode was a protecting factor.Conclusion: Clinical characteristics may play an important role in predicting nonadherence. Doctors may have to pay much attention on patients with these factors and should keep on discussing them with patients.